Linear epitopes of SARS-CoV-2 spike protein elicit neutralizing antibodies in COVID-19 patients
- PMID: 32895485
- PMCID: PMC7475724
- DOI: 10.1038/s41423-020-00523-5
Linear epitopes of SARS-CoV-2 spike protein elicit neutralizing antibodies in COVID-19 patients
Conflict of interest statement
The authors declare no competing interests.
Figures
Similar articles
-
Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike.Nature. 2020 Aug;584(7821):450-456. doi: 10.1038/s41586-020-2571-7. Epub 2020 Jul 22. Nature. 2020. PMID: 32698192
-
A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2.Science. 2020 Aug 7;369(6504):650-655. doi: 10.1126/science.abc6952. Epub 2020 Jun 22. Science. 2020. PMID: 32571838 Free PMC article.
-
On the molecular determinants of the SARS-CoV-2 attack.Clin Immunol. 2020 Jun;215:108426. doi: 10.1016/j.clim.2020.108426. Epub 2020 Apr 18. Clin Immunol. 2020. PMID: 32311462 Free PMC article. No abstract available.
-
Targeting SARS-CoV2 Spike Protein Receptor Binding Domain by Therapeutic Antibodies.Biomed Pharmacother. 2020 Oct;130:110559. doi: 10.1016/j.biopha.2020.110559. Epub 2020 Aug 1. Biomed Pharmacother. 2020. PMID: 32768882 Free PMC article. Review.
-
Receptor-binding domain-specific human neutralizing monoclonal antibodies against SARS-CoV and SARS-CoV-2.Signal Transduct Target Ther. 2020 Sep 22;5(1):212. doi: 10.1038/s41392-020-00318-0. Signal Transduct Target Ther. 2020. PMID: 32963228 Free PMC article. Review.
Cited by
-
Longitudinal neutralization activities on authentic Omicron variant provided by three doses of BBIBP-CorV vaccination during one year.Proteomics. 2023 Jan;23(2):e2200306. doi: 10.1002/pmic.202200306. Epub 2022 Oct 17. Proteomics. 2023. PMID: 36205637 Free PMC article.
-
Exploring antibody repurposing for COVID-19: beyond presumed roles of therapeutic antibodies.Sci Rep. 2021 May 13;11(1):10220. doi: 10.1038/s41598-021-89621-6. Sci Rep. 2021. PMID: 33986382 Free PMC article.
-
Bioinformatic Analysis of B- and T-cell Epitopes from SARS-CoV-2 Structural Proteins and their Potential Cross-reactivity with Emerging Variants and other Human Coronaviruses.Arch Med Res. 2022 Nov;53(7):694-710. doi: 10.1016/j.arcmed.2022.10.007. Epub 2022 Nov 3. Arch Med Res. 2022. PMID: 36336501 Free PMC article.
-
DNA vaccine candidate encoding SARS-CoV-2 spike proteins elicited potent humoral and Th1 cell-mediated immune responses in mice.PLoS One. 2021 Mar 22;16(3):e0248007. doi: 10.1371/journal.pone.0248007. eCollection 2021. PLoS One. 2021. PMID: 33750975 Free PMC article.
-
Immunodominant Linear B-Cell Epitopes of SARS-CoV-2 Spike, Identified by Sera from K18-hACE2 Mice Infected with the WT or Variant Viruses.Vaccines (Basel). 2022 Feb 7;10(2):251. doi: 10.3390/vaccines10020251. Vaccines (Basel). 2022. PMID: 35214711 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
